Table 4 Association between baseline and AVF creation characteristics and secondary AVF failure among 100 participants
Factors | Secondary AVF failure* (N = 83) | P value** | OR (95%CI) | |
|---|---|---|---|---|
Yes (n = 14) | No (n = 69) | |||
Age (years) | 67.21 ± 18.89 | 60.33 ± 17.14 | 0.182 |  |
Male | 9 (64.29) | 25 (36.23) | 0.051 | 3.168 (0.956–10.501) |
Diabetes mellitus | 6 (42.86) | 23 (30.00) | 0.348 | 0.667 (0.207–2.150) |
Dyslipidemia | 4 (28.57) | 18 (26.09) | 0.577 | 0.923 (0.246–3.469) |
Type of arteriovenous anastomosis (End-to-side arteriovenous anastomosis) | 11 (78.57) | 59 (85.51) | 0.380 | 1.609 (0.381–6.804) |
Operation time (minutes) | 84.64 ± 21.35 | 71.52 ± 21.18 | 0.038 |  |
Site of AVF creation (Radiocephalicfistula) | 11 (78.57) | 54 (78.26) | 0.644 | 0.982 (0.242–3.977) |
History of AVF creation (Second time or more) | 3 (21.42) | 3 (4.34) | 0.057 | 6.000 (1.071–33.605) |
AVF creation before hemodialysis initiation | 5 (35.71) | 40 (57.97) | 0.131 | 0.406 (0.122–1.328) |